サマリー

受託研究機関（CRO）の世界市場 2022-2026 年
Technavioは受託研究機関（CRO）市場を監視しており、2022-2026年の間に400億ドルの成長が見込まれ、予測期間中にCAGR 10.06%で加速しています。当レポートでは、受託研究機関（CRO）市場の全体分析、市場規模・予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境について最新の分析を提供しています。市場は、バイオ医薬品産業の成長、世界的な研究開発費の増加がCROの業界統計に拍車をかけること、臨床試験の規制が受託研究機関の成長を促進すること、などによって牽引されます。
開発業務受託機関（CRO）市場の分析には、エンドユーザーセグメントと地理的状況が含まれます。
Technavioの受託研究機関（cro）市場は以下のように区分されます。
エンドユーザー別
- 製薬会社、バイオ製薬会社
- 医療機器メーカー
- 学術機関
地域別
- 北米
- 欧州
- APAC
- その他の地域 (ROW)
本調査では、今後数年間の医薬品開発業務受託機関（cro）市場の成長を牽引する主な要因の一つとして、croに対する需要の高まりを挙げています。また、臨床試験数の増加、アウトソーシングの傾向の高まり、croサービスの利用によるコスト削減が、市場での大きな需要につながるだろう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当社の委託研究機関（cro）市場に関するレポートは、以下の分野をカバーしています。
- 医薬品開発業務受託機関（cro）市場のサイジング
- 開発業務受託機関（cro）市場の予測
- 開発業務受託機関（cro）市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Azelix LLC、BioAgile Therapeutics Pvt.Ltd, Charles River Laboratories International Inc.、Clinical Trial Service BV、Clinical Research Organization (cro)市場の主要ベンダーについて詳細分析を提供している。Clinical Trial Service BV、Eurofins Scientific SE、Firma Clinical Research LLC、Frontage Holdings Corp、GENETICIST Inc、Guires Ltd.、ICON plc、IQVIA Holdings Inc.、Laboratory Corp.パレクセル・インターナショナル、ファーマロン北京、PSI CRO AG、ジェネティシスト、ギレス、アイコン、IQVIAホールディングス、ラボラトリー・コーポレーション・オブ・アメリカ・ホールディングス、リニカルLtd.、PSI CRO AG、Syneos Health Inc.、Thermo Fisher Scientific Inc.、WuXi AppTec Co.Ltd.、Pharmaron Beijing Co., Ltd.、PSI CRO AG、Synos Health Inc.、Thermo Fisher Scientific Inc.、WuXi AppTec Co.また、受託研究機関（cro）市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/contract-research-organization-cro-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
o Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
o 5.2 Comparison by End-user
o Exhibit 26: Chart on Comparison by End-user
o Exhibit 27: Data Table on Comparison by End-user
o 5.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
o 5.4 Medical device companies - Market size and forecast 2021-2026
o Exhibit 32: Chart on Medical device companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Medical device companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Medical device companies - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Medical device companies - Year-over-year growth 2021-2026 (%)
o 5.5 Academic institutes - Market size and forecast 2021-2026
o Exhibit 36: Chart on Academic institutes - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Academic institutes - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Academic institutes - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Academic institutes - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by End-user
o Exhibit 40: Market opportunity by End-user ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share by geography 2021-2026 (%)
o Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 82: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Charles River Laboratories International Inc.
o Exhibit 89: Charles River Laboratories International Inc. - Overview
o Exhibit 90: Charles River Laboratories International Inc. - Business segments
o Exhibit 91: Charles River Laboratories International Inc. - Key news
o Exhibit 92: Charles River Laboratories International Inc. - Key offerings
o Exhibit 93: Charles River Laboratories International Inc. - Segment focus
o 10.4 Eurofins Scientific SE
o Exhibit 94: Eurofins Scientific SE - Overview
o Exhibit 95: Eurofins Scientific SE - Business segments
o Exhibit 96: Eurofins Scientific SE - Key news
o Exhibit 97: Eurofins Scientific SE - Key offerings
o Exhibit 98: Eurofins Scientific SE - Segment focus
o 10.5 ICON plc
o Exhibit 99: ICON plc - Overview
o Exhibit 100: ICON plc - Product / Service
o Exhibit 101: ICON plc - Key offerings
o 10.6 IQVIA Holdings Inc.
o Exhibit 102: IQVIA Holdings Inc. - Overview
o Exhibit 103: IQVIA Holdings Inc. - Business segments
o Exhibit 104: IQVIA Holdings Inc. - Key news
o Exhibit 105: IQVIA Holdings Inc. - Key offerings
o Exhibit 106: IQVIA Holdings Inc. - Segment focus
o 10.7 Laboratory Corp. of America Holdings
o Exhibit 107: Laboratory Corp. of America Holdings - Overview
o Exhibit 108: Laboratory Corp. of America Holdings - Business segments
o Exhibit 109: Laboratory Corp. of America Holdings - Key news
o Exhibit 110: Laboratory Corp. of America Holdings - Key offerings
o Exhibit 111: Laboratory Corp. of America Holdings - Segment focus
o 10.8 Medpace Holdings Inc.
o Exhibit 112: Medpace Holdings Inc. - Overview
o Exhibit 113: Medpace Holdings Inc. - Product / Service
o Exhibit 114: Medpace Holdings Inc. - Key offerings
o 10.9 PAREXEL International Corp.
o Exhibit 115: PAREXEL International Corp. - Overview
o Exhibit 116: PAREXEL International Corp. - Product / Service
o Exhibit 117: PAREXEL International Corp. - Key offerings
o 10.10 Syneos Health Inc.
o Exhibit 118: Syneos Health Inc. - Overview
o Exhibit 119: Syneos Health Inc. - Business segments
o Exhibit 120: Syneos Health Inc. - Key offerings
o Exhibit 121: Syneos Health Inc. - Segment focus
o 10.11 Thermo Fisher Scientific Inc.
o Exhibit 122: Thermo Fisher Scientific Inc. - Overview
o Exhibit 123: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 124: Thermo Fisher Scientific Inc. - Key news
o Exhibit 125: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 126: Thermo Fisher Scientific Inc. - Segment focus
o 10.12 WuXi AppTec Co. Ltd.
o Exhibit 127: WuXi AppTec Co. Ltd. - Overview
o Exhibit 128: WuXi AppTec Co. Ltd. - Business segments
o Exhibit 129: WuXi AppTec Co. Ltd. - Key offerings
o Exhibit 130: WuXi AppTec Co. Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations
o growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
o product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on End-user - Market share 2021-2026 (%)
Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by End-user
Exhibits27: Data Table on Comparison by End-user
Exhibits28: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Medical device companies - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Medical device companies - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Medical device companies - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Medical device companies - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Academic institutes - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Academic institutes - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Academic institutes - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Academic institutes - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by End-user ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share by geography 2021-2026 (%)
Exhibits43: Data Table on Market share by geography 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity by geography ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Charles River Laboratories International Inc. - Overview
Exhibits90: Charles River Laboratories International Inc. - Business segments
Exhibits91: Charles River Laboratories International Inc. - Key news
Exhibits92: Charles River Laboratories International Inc. - Key offerings
Exhibits93: Charles River Laboratories International Inc. - Segment focus
Exhibits94: Eurofins Scientific SE - Overview
Exhibits95: Eurofins Scientific SE - Business segments
Exhibits96: Eurofins Scientific SE - Key news
Exhibits97: Eurofins Scientific SE - Key offerings
Exhibits98: Eurofins Scientific SE - Segment focus
Exhibits99: ICON plc - Overview
Exhibits100: ICON plc - Product / Service
Exhibits101: ICON plc - Key offerings
Exhibits102: IQVIA Holdings Inc. - Overview
Exhibits103: IQVIA Holdings Inc. - Business segments
Exhibits104: IQVIA Holdings Inc. - Key news
Exhibits105: IQVIA Holdings Inc. - Key offerings
Exhibits106: IQVIA Holdings Inc. - Segment focus
Exhibits107: Laboratory Corp. of America Holdings - Overview
Exhibits108: Laboratory Corp. of America Holdings - Business segments
Exhibits109: Laboratory Corp. of America Holdings - Key news
Exhibits110: Laboratory Corp. of America Holdings - Key offerings
Exhibits111: Laboratory Corp. of America Holdings - Segment focus
Exhibits112: Medpace Holdings Inc. - Overview
Exhibits113: Medpace Holdings Inc. - Product / Service
Exhibits114: Medpace Holdings Inc. - Key offerings
Exhibits115: PAREXEL International Corp. - Overview
Exhibits116: PAREXEL International Corp. - Product / Service
Exhibits117: PAREXEL International Corp. - Key offerings
Exhibits118: Syneos Health Inc. - Overview
Exhibits119: Syneos Health Inc. - Business segments
Exhibits120: Syneos Health Inc. - Key offerings
Exhibits121: Syneos Health Inc. - Segment focus
Exhibits122: Thermo Fisher Scientific Inc. - Overview
Exhibits123: Thermo Fisher Scientific Inc. - Business segments
Exhibits124: Thermo Fisher Scientific Inc. - Key news
Exhibits125: Thermo Fisher Scientific Inc. - Key offerings
Exhibits126: Thermo Fisher Scientific Inc. - Segment focus
Exhibits127: WuXi AppTec Co. Ltd. - Overview
Exhibits128: WuXi AppTec Co. Ltd. - Business segments
Exhibits129: WuXi AppTec Co. Ltd. - Key offerings
Exhibits130: WuXi AppTec Co. Ltd. - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations